Pharmacokinetics and pharmacodynamics of vincristine sulfate liposome injection (VSLI) in adults with acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacokinetics and pharmacodynamics of vincristine sulfate liposome injection (VSLI) in adults with acute lymphoblastic leukemia

Published:2013-08 Issue: Volume: Page:n/a-n/a
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Silverman Jeffrey A.¹,Reynolds Laurie²,Deitcher Steven R.¹

Affiliation:

1. Talon Therapeutics, Inc.; South San Francisco; CA; USA

2. ICON Development Solutions; Hanover; MD; USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jcph.155/fullpdf

Reference38 articles.

1. The vinca alkaloids: a new class of oncolytic agents;Johnson;Cancer Res.,1963

2. Vincristine revisited;Gidding;Crit Rev Oncol Hematol.,1999

3. Pharmacology, bio-analysis and pharmacokinetics of the vinca alkaloids and semi-synthetic derivatives (review);van Tellingen;Anticancer Res.,1992

4. Genetic and related effects of Vinca rosea alkaloids;Degraeve;Mutat Res.,1978

5. Vincristine pharmacokinetics after repetitive dosing in children;Gidding;Cancer Chemother Pharmacol.,1999

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advance in phytonanomedicine and mineral nanomedicine delivery system of the treatment for acute myeloid leukemia;Journal of Nanobiotechnology;2023-07-26

2. Lysosomal nanotoxicity: Impact of nanomedicines on lysosomal function;Advanced Drug Delivery Reviews;2023-06

3. Development of Novel siRNA Therapeutics: A Review with a Focus on Inclisiran for the Treatment of Hypercholesterolemia;International Journal of Molecular Sciences;2023-02-16

4. Proactive therapeutic drug monitoring of vincristine in pediatric and adult cancer patients: current supporting evidence and future efforts;Archives of Toxicology;2022-11-23

5. Emerging Nanotherapeutic Approaches to Overcome Drug Resistance in Cancers with Update on Clinical Trials;Pharmaceutics;2022-04-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3